Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001640334-24-001893
Filing Date
2024-12-16
Accepted
2024-12-16 16:05:11
Documents
4

Document Format Files

Seq Description Document Type Size
1 POS AM lxrp_posam.htm POS AM 248306
2 CONSENT lxrp_ex231.htm EX-23.1 2238
3 lxrp_posamimg5.jpg GRAPHIC 14685
4 lxrp_posamimg6.jpg GRAPHIC 14685
  Complete submission text file 0001640334-24-001893.txt   292425
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: POS AM | Act: 33 | File No.: 333-277863 | Film No.: 241551798
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)